ARTICLE | Company News
Cypros other research news
July 11, 1994 7:00 AM UTC
The Carlsbad, Calif., company received a $460,000 Phase II SBIR grant from the National Institutes of Health to support development of drugs that block neuronal calcium channels. The channels control ...